![Ronald R. Zimmerman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald R.
Zimmerman was the founder of PLx Pharma, Inc. (founded in 2002) and MediGen Group LLC (founded in 2001) where he held the title of Managing Director.
He also held the position of Director at Nanospectra Biosciences, Inc. and was a Member-Advisory Board at BioImagene, Inc.
| Empresas | Cargo | Fin |
|---|---|---|
| PLX PHARMA WINDDOWN CORP. | Fundador | - |
BioImagene, Inc.
 BioImagene, Inc. Information Technology ServicesTechnology Services Develops digital pathology solutions for medical diagnosis, detection and therapy | Corporate Officer/Principal | - |
MediGen Group LLC
 MediGen Group LLC Investment ManagersFinance MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks | Fundador | - |
PLx Pharma, Inc. /Old/
 PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Develops formulations of non steroidal anti-inflammatory drugs | Fundador | - |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic products | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 5 |
|---|---|
PLx Pharma, Inc. /Old/
PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Develops formulations of non steroidal anti-inflammatory drugs | Health Technology |
BioImagene, Inc.
BioImagene, Inc. Information Technology ServicesTechnology Services Develops digital pathology solutions for medical diagnosis, detection and therapy | Technology Services |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic products | Health Technology |
MediGen Group LLC
MediGen Group LLC Investment ManagersFinance MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks | Finance |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops liquid-filled aspirin capsules for pain management | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
